Business Standard

Supriya Lifescience standalone net profit declines 71.04% in the September 2022 quarter

Image

Capital Market

Sales decline 24.21% to Rs 112.17 crore

Net profit of Supriya Lifescience declined 71.04% to Rs 16.86 crore in the quarter ended September 2022 as against Rs 58.22 crore during the previous quarter ended September 2021. Sales declined 24.21% to Rs 112.17 crore in the quarter ended September 2022 as against Rs 148.01 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales112.17148.01 -24 OPM %25.4652.77 -PBDT30.3980.21 -62 PBT27.4277.75 -65 NP16.8658.22 -71

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 11 2022 | 8:38 AM IST

Explore News